These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 25723098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin through Inhibition of UGT-Mediated Metabolism.
    Dong D, Quan E, Yuan X, Xie Q, Li Z, Wu B.
    Mol Pharm; 2017 Sep 05; 14(9):2864-2874. PubMed ID: 27983856
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
    Ghassemi S, Haeri A, Shahhosseini S, Dadashzadeh S.
    AAPS PharmSciTech; 2018 Oct 05; 19(7):2961-2970. PubMed ID: 30030724
    [Abstract] [Full Text] [Related]

  • 6. Dual Strategy for Improving the Oral Bioavailability of Resveratrol: Enhancing Water Solubility and Inhibiting Glucuronidation.
    Li Y, Zhang R, Zhang Q, Luo M, Lu F, He Z, Jiang Q, Zhang T.
    J Agric Food Chem; 2021 Aug 18; 69(32):9249-9258. PubMed ID: 34357767
    [Abstract] [Full Text] [Related]

  • 7. Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases.
    Zhang Y, Zhang M, Hu G, Zhang Z, Song R.
    J Ethnopharmacol; 2020 Mar 25; 250():112528. PubMed ID: 31884038
    [Abstract] [Full Text] [Related]

  • 8. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems.
    Sessa M, Balestrieri ML, Ferrari G, Servillo L, Castaldo D, D'Onofrio N, Donsì F, Tsao R.
    Food Chem; 2014 Mar 15; 147():42-50. PubMed ID: 24206683
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability.
    Izgelov D, Cherniakov I, Aldouby Bier G, Domb AJ, Hoffman A.
    Mol Pharm; 2018 Apr 02; 15(4):1548-1555. PubMed ID: 29537855
    [Abstract] [Full Text] [Related]

  • 10. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
    Siu FY, Ye S, Lin H, Li S.
    Int J Nanomedicine; 2018 Apr 02; 13():4133-4144. PubMed ID: 30038494
    [Abstract] [Full Text] [Related]

  • 11. Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms.
    Brill SS, Furimsky AM, Ho MN, Furniss MJ, Li Y, Green AG, Bradford WW, Green CE, Kapetanovic IM, Iyer LV.
    J Pharm Pharmacol; 2006 Apr 02; 58(4):469-79. PubMed ID: 16597364
    [Abstract] [Full Text] [Related]

  • 12. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H, Kume T.
    Drug Metab Dispos; 2005 Mar 02; 33(3):403-12. PubMed ID: 15608137
    [Abstract] [Full Text] [Related]

  • 13. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
    Hoehle SI, Pfeiffer E, Metzler M.
    Mol Nutr Food Res; 2007 Aug 02; 51(8):932-8. PubMed ID: 17628876
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept.
    Maharao NV, Joshi AA, Gerk PM.
    Biopharm Drug Dispos; 2017 Mar 02; 38(2):139-154. PubMed ID: 27925249
    [Abstract] [Full Text] [Related]

  • 15. Enhancing in vivo oral bioavailability of cajaninstilbene acid using UDP-glucuronosyl transferase inhibitory excipient containing self-microemulsion.
    Yang FF, Ji CY, Cong ZQ, Ma SQ, Liu CY, Pan RL, Chang Q, Ji YB, Liao YH.
    Colloids Surf B Biointerfaces; 2020 Sep 02; 193():111069. PubMed ID: 32371286
    [Abstract] [Full Text] [Related]

  • 16. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
    Gorain B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal TK.
    Colloids Surf B Biointerfaces; 2014 Mar 01; 115():286-94. PubMed ID: 24388859
    [Abstract] [Full Text] [Related]

  • 17. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
    Narayanan R, LeDuc B, Williams DA.
    Life Sci; 2004 Apr 02; 74(20):2527-39. PubMed ID: 15010263
    [Abstract] [Full Text] [Related]

  • 18. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
    Iwuchukwu OF, Ajetunmobi J, Ung D, Nagar S.
    Drug Metab Dispos; 2009 Aug 02; 37(8):1726-32. PubMed ID: 19406951
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytochromes P450 Inhibitory Excipient-Based Self-Microemulsions for the Improved Bioavailability of Protopanaxatriol and Protopanaxadiol: Preparation and Evaluation.
    Yang F, Zhou J, Liu C, Hu X, Pan R, Chang Q, Liu X, Liao Y.
    Planta Med; 2017 Mar 02; 83(5):453-460. PubMed ID: 27220080
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.